Brian Johnson, MD, PhD, affiliated with SUNY Upstate in Syracuse, New York, has published research on addiction, attention-deficit/hyperactivity disorder (ADHD), and schizophrenia/schizoaffective disorders. His work includes studies on treatment approaches and predictors in patients with substance use disorders and comorbid ADHD, as well as investigations into the efficacy and safety of aripiprazole once-monthly for maintenance treatment in bipolar I disorder. Johnson's publications span from 2017 to 2024 in Psychiatrist.com journals.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
